Business

January 2, 2014 1:02 PM

Salix completes acquisition of Santarus

Salix Pharmaceuticals reported Thursday that it has completed its $2.6 billion acquisition of the specialty drug company Santarus.

Related content

Suggested for you

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs